Revelation Biosciences Inc. has announced the immediate exercise of certain outstanding warrants, allowing holders to purchase up to 13,065,000 shares of common stock at a reduced exercise price of $0.86 per share. In connection with this transaction, the exercising holders will also receive new Class J warrants to purchase up to 26,130,000 shares of common stock in a private placement. The new warrants will become exercisable following stockholder approval and will have a five-year term. The company expects to raise approximately $11 million in gross proceeds from the exercise of the existing warrants and plans to file a resale registration statement for the shares issuable upon exercise of the new warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revelation Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1130330) on January 23, 2026, and is solely responsible for the information contained therein.